Nearly 10 percent of the world’s cell and gene therapy companies are based in Greater Philadelphia, and the industry now employs more than 7,000 people in the region, a sign of the depth and breadth of this fast-growing industry, according to a study commissioned by the Chamber of Commerce for Greater Philadelphia.
Cell Surface Bio was spun out of Integral Molecular, a 23-year-old University City biotechnology company that uses its expertise in targeted biology antibody discovery, virology, and protein engineering to help drug developers advance potential new therapies for difficult to treat diseases.
We value your feedback and inquiries. Whether you have questions, suggestions, or need assistance, our team is here to help. Please reach out to us through the contact form below, and we will get back to you promptly.
